Pioglitazone for the treatment of Alzheimer’s disease

Daniela Galimberti, PhD from the University of Milan, Milan, Italy discusses a study on pioglitazone for the treatment of Alzheimer’s disease at the 2017 Congress of the European Academy of Neurology (EAN) in Amsterdam, the Netherlands. The drug acts on a receptor involved in inflammatory mechanisms and the rationale is to interfere with inflammation in Alzheimer’s disease.

Share this video  
24th June 2017